» Articles » PMID: 22361517

Genetic Determinants of the Ankle-brachial Index: a Meta-analysis of a Cardiovascular Candidate Gene 50K SNP Panel in the Candidate Gene Association Resource (CARe) Consortium

Abstract

Background: Candidate gene association studies for peripheral artery disease (PAD), including subclinical disease assessed with the ankle-brachial index (ABI), have been limited by the modest number of genes examined. We conducted a two stage meta-analysis of ∼50,000 SNPs across ∼2100 candidate genes to identify genetic variants for ABI.

Methods And Results: We studied subjects of European ancestry from 8 studies (n=21,547, 55% women, mean age 44-73 years) and African American ancestry from 5 studies (n=7267, 60% women, mean age 41-73 years) involved in the candidate gene association resource (CARe) consortium. In each ethnic group, additive genetic models were used (with each additional copy of the minor allele corresponding to the given beta) to test each SNP for association with continuous ABI (excluding ABI>1.40) and PAD (defined as ABI<0.90) using linear or logistic regression with adjustment for known PAD risk factors and population stratification. We then conducted a fixed-effects inverse-variance weighted meta-analyses considering a p<2×10(-6) to denote statistical significance.

Results: In the European ancestry discovery meta-analyses, rs2171209 in SYTL3 (β=-0.007, p=6.02×10(-7)) and rs290481 in TCF7L2 (β=-0.008, p=7.01×10(-7)) were significantly associated with ABI. None of the SNP associations for PAD were significant, though a SNP in CYP2B6 (p=4.99×10(-5)) was among the strongest associations. These 3 genes are linked to key PAD risk factors (lipoprotein(a), type 2 diabetes, and smoking behavior, respectively). We sought replication in 6 population-based and 3 clinical samples (n=15,440) for rs290481 and rs2171209. However, in the replication stage (rs2171209, p=0.75; rs290481, p=0.19) and in the combined discovery and replication analysis the SNP-ABI associations were no longer significant (rs2171209, p=1.14×10(-3); rs290481, p=8.88×10(-5)). In African Americans, none of the SNP associations for ABI or PAD achieved an experiment-wide level of significance.

Conclusions: Genetic determinants of ABI and PAD remain elusive. Follow-up of these preliminary findings may uncover important biology given the known gene-risk factor associations. New and more powerful approaches to PAD gene discovery are warranted.

Citing Articles

Epidemiology and genetic determination of measures of peripheral vascular health in the Long Life Family Study.

Fricke D, Cvejkus R, Barinas-Mitchell E, Feitosa M, Murabito J, Acharya S Aging (Albany NY). 2025; 17(2):464-481.

PMID: 40013929 PMC: 11892930. DOI: 10.18632/aging.206204.


Genetic Variants at the 9p21.3 Locus Are Associated with Risk for Non-Compressible Artery Disease: Results from the ARTPER Study.

Via M, Pera G, Fores R, Costa-Garrido A, Heras A, Baena-Diez J Genes (Basel). 2024; 15(1).

PMID: 38275585 PMC: 10815029. DOI: 10.3390/genes15010002.


Unveiling the Genetic Footprint: Exploring Somatic Mutations in Peripheral Arterial Disease Progression.

Salybekov A, Hassanpour M Biomedicines. 2023; 11(8).

PMID: 37626784 PMC: 10452092. DOI: 10.3390/biomedicines11082288.


Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease.

Poredos P, Sabovic M, Bozic Mijovski M, Nikolajevic J, Antignani P, Paraskevas K Int J Mol Sci. 2022; 23(19).

PMID: 36233355 PMC: 9569699. DOI: 10.3390/ijms231912054.


The Genetic Architecture of the Etiology of Lower Extremity Peripheral Artery Disease: Current Knowledge and Future Challenges in the Era of Genomic Medicine.

Butnariu L, Gorduza E, Florea L, Tarca E, Moisa S, Tradafir L Int J Mol Sci. 2022; 23(18).

PMID: 36142394 PMC: 9499674. DOI: 10.3390/ijms231810481.


References
1.
Erqou S, Thompson A, Di Angelantonio E, Saleheen D, Kaptoge S, Marcovina S . Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. J Am Coll Cardiol. 2010; 55(19):2160-7. DOI: 10.1016/j.jacc.2009.10.080. View

2.
Murray G, Butcher I, Heald C, Lee R, Chambless L, Folsom A . Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008; 300(2):197-208. PMC: 2932628. DOI: 10.1001/jama.300.2.197. View

3.
Kullo I, Turner S, Kardia S, Mosley Jr T, Boerwinkle E, de Andrade M . A genome-wide linkage scan for ankle-brachial index in African American and non-Hispanic white subjects participating in the GENOA study. Atherosclerosis. 2005; 187(2):433-8. DOI: 10.1016/j.atherosclerosis.2005.10.003. View

4.
Newman A, Shemanski L, Manolio T, Cushman M, Mittelmark M, Polak J . Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999; 19(3):538-45. DOI: 10.1161/01.atv.19.3.538. View

5.
Volpato S, Vigna G, McDermott M, Cavalieri M, Maraldi C, Lauretani F . Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study). Am J Cardiol. 2010; 105(12):1825-30. PMC: 2888047. DOI: 10.1016/j.amjcard.2010.01.370. View